To begin to address this, we performed gene expression profiling of mammary tumor EpRas cells that had been allowed to adopt an EMT program after long-term treatment with transforming growth factor beta 1 (TGF-β1) for 2 weeks. This evidence concerns the gene TGFB1 and breast cancer.